Oxurion NV

Oxurion NVverified

OXUR.BR

Price:

$0.0001

Market Cap:

$1.23M

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV ...[Read more]

Industry

Biotechnology

IPO Date

2006-07-07

Stock Exchange

EURONEXT

Ticker

OXUR.BR

The PE Ratio as of June 2024 (TTM) for Oxurion NV (OXUR.BR) is -0.01

According to Oxurion NV’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -92.36% compared to the average of -0.13 of the last 4 quarters.

Oxurion NV (OXUR.BR) Historical PE Ratio (quarterly & annually)

How has OXUR.BR PE Ratio performed in the past?

The mean historical PE Ratio of Oxurion NV over the last ten years is -1.59. The current -0.01 PE Ratio has changed -36.97% with respect to the historical average. Over the past ten years (40 quarters), OXUR.BR's PE Ratio was at its highest in in the December 2012 quarter at 61.37. The PE Ratio was at its lowest in in the September 2010 quarter at -39.55.

Quarterly (TTM)
Annual

Average

-1.59

Median

-2.29

Minimum

-4.62

Maximum

5.39

Oxurion NV (OXUR.BR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Oxurion NV PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 60.24%

Maximum Annual PE Ratio = 5.39

Minimum Annual Increase = -455.83%

Minimum Annual PE Ratio = -4.62

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.052.50%
2022-0.05-97.87%
2021-2.39-31.51%
2020-3.4960.24%
2019-2.18-39.19%
2018-3.58-166.55%
20175.39-455.83%
2016-1.51-55.03%
2015-3.37-27.14%
2014-4.62-116.28%

Oxurion NV (OXUR.BR) Average PE Ratio

How has OXUR.BR PE Ratio performed in the past?

The current PE Ratio of Oxurion NV (OXUR.BR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.83

5-year avg

-1.63

10-year avg

-1.59

Oxurion NV (OXUR.BR) PE Ratio vs. Peers

How is OXUR.BR’s PE Ratio compared to its peers?

Oxurion NV’s PE Ratio is greater than Biocartis Group NV (-0.32), greater than Mithra Pharmaceuticals SA (-0.09), greater than MDxHealth SA (-17.01), greater than Celyad Oncology SA (-1.00), greater than argenx SE (-69.49),

Build a custom stock screener for Oxurion NV (OXUR.BR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oxurion NV using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oxurion NV (OXUR.BR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oxurion NV or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Oxurion NV's PE Ratio?

How is the PE Ratio calculated for Oxurion NV (OXUR.BR)?

What is the highest PE Ratio for Oxurion NV (OXUR.BR)?

What is the 3-year average PE Ratio for Oxurion NV (OXUR.BR)?

What is the 5-year average PE Ratio for Oxurion NV (OXUR.BR)?

How does the current PE Ratio for Oxurion NV (OXUR.BR) compare to its historical average?